SHL to give talk at the PDA Korea conference

SHL will participate in this year’s conference hosted by the PDA Korea chapter titled the “2020 PDA Asia Pacific Aseptic Processing of Biopharmaceuticals” as a presenter on October 14, Korea Standard Time (KST). The three-day event runs from October 12-14.

As a first-time participant this year, SHL’s Senior Director of Commercial Operation Lyndon Wild will give a talk on how SHL’s Molly® autoinjector, built with a robust core technology, enables a mix of customizations for industrial design, manufacturing, as well as end user needs. The talk is titled “The “Customizable Platform” Paradox: A Flexible Design and Development Model for Platform Devices,” and will be delivered online by Lyndon on October 14, between 16:30-17:00 Korea Standard Time (KST).

About SHL Medical

As a world-leading solutions provider of advanced drug delivery systems, SHL Medical is the partner of choice for many leading pharma and biotech companies. Driven by our company purpose – Enabling Patients’ Independence – we offer patient-centric solutions for the design, development, and manufacturing of autoinjectors, pen injectors, as well as innovative specialty delivery systems for large-volume and high-viscosity formulations. We also offer final assembly, labeling, and packaging solutions for our drug delivery systems.

In response to the rising trend in home therapy, SHL has increased developmental work in the digital healthcare sector to help improve the drug delivery ecosystem.

Located across Switzerland, Taiwan, Sweden, and the US, our global team of experts collaborate seamlessly as one team in utilizing our comprehensive in-house manufacturing capabilities. Our solutions offer customization and optimization for each project while proactively weaving sustainability-driven measures into our designs and processes to contribute to a cleaner earth.

For additional information, visit www.shl-medical.com

Media contact: info@shl-medical.com